To establish a sensitive and specific method for simultaneous determination of gestodene,
etonogestrel and ethinylestradiol in plasma by LC-MS/MS, plasma samples were extracted …

Two monophasic oral contraceptives containing gestodene (GTD, 15 μg) and
ethinylestradiol (EE, 30 μg) or norgestimate (NGS, 250 μg) and EE (35 μg) were compared …

The clinical and metabolic effects of a short-term treatment with a combination contraceptive
pill containing 30 mcg ethinylestradiol and 75 mcg gestodene were evaluated in a group of …

Oral contraceptives inhibit ovarian follicular growth by suppressing the release of
gonadotropins from the pituitary. We studied basal and gonadotropin-releasing hormone …

The efficacy, cycle control, subjective complaints, and safety of monophasic preparations of
the oral contraceptives containing gestodene 75 mcg plus ethinyl estradiol 30 mcg versus …

The newer progestogens desogestrel, norgestimate, gestodene, dienogest and nomegestrol
share the common property of having weak or no androgenic effects, but there is great …

Objectives A new method for the quantitative determination of 17alpha-ethinylestradiol-
17beta (EE2) in serum is presented here based on the principle of isotope dilution mass …

This open, prospective, noncomparative study evaluated clinical and metabolic aspects of
the use of a contraceptive combination of ethinyl estradiol (30 μg) and gestodene (75 μg) …

The metabolism of the progesteron gestodene has been studied in human liver cytosol and
microsomal incubations. Extraction with diethyl ether was followed by radiometric HPLC …